image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

SIGN UP NOW
Primary Recommendations

Seraphine - Eps forecasts: 8.5p, 13.4p, 15.9p

February 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BUMP
  • Price:
  • 218p
Despite some predicting that the Covid lockdown restrictions in March 2020 were going to lead to a baby boom - ONS data suggests birth rates in England and Wales for 2021 ended up being the lowest ever recorded (since 1938). But some statisticians are drawing parallels with the current state of the pandemic with the ending of World War II, which was characterized by a massive upswing in birth rates in the US and other countries – the so-called “Baby Boom.” This then is a reasonable tailwind for Seraphine, an international maternity fashion label.  Seraphine hasn’t crowned itself with glory so far. Its flotation last August was a total flop with a profit warning just three months later. Demand wasn’t the problem; instead, Seraphine ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Seraphine (March 2022)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW